ORIGINAL ARTICLE |
|
Year : 2017 | Volume
: 21
| Issue : 6 | Page : 823-829 |
|
Cardiovascular risk factors in children and adolescents with subclinical hypothyroidism
Yogesh Yadav1, Uma Kaimal Saikia1, Dipti Sarma1, Manoj Hazarika2
1 Department of Endocrinology, Gauhati Medical College, Guwahati, Assam, India 2 Department of Radiology, Assam Medical College, Dibrugarh, Assam, India
Correspondence Address:
Yogesh Yadav Department of Endocrinology, Gauhati Medical College, Guwahati - 781 032, Assam India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijem.IJEM_153_17
|
|
Background: Subclinical hypothyroidism (SCH) is a commonly encountered entity in day-to-day clinical practice and has been associated with adverse cardiovascular risk profile in adults and children. Data on children and adolescents with SCH, from India, are limited. Materials and Methods: This study was a cross-sectional case–control study, conducted at a tertiary care center in Northeast India. Twenty-seven children and adolescents aged 11 ± 2.4 years with SCH and thyroid-stimulating hormone >7.5 mIU/L were included in the study along with 20 age-, gender-, and height-matched controls. Multiple clinical, biochemical, and radiological cardiovascular risk factors were assessed and compared between the two groups. Results: Body mass index (BMI) (P = 0.048), waist circumference (P = 0.008), waist to height ratio (P = 0.007), low-density lipoprotein cholesterol (P = 0.04), triglycerides (TGs) (P = 0.038), TGs to high-density lipoprotein (HDL) cholesterol ratio (P = 0.005), non-HDL cholesterol (P = 0.019), fasting insulin (P = 0.006), and homeostasis model assessment of insulin resistance (P = 0.007) were found to be significantly higher while free T4 (P = 0.002) and HDL cholesterol (P = 0.019) were found to be significantly lower in SCH subjects compared to controls. On multiple regression analysis, BMI was found to have significant association with multiple cardiovascular risk factors. Conclusion: Children and adolescents with SCH were found to have adverse cardiovascular risk profile. Long-term follow-up studies are required to assess the clinical significance of these findings and requirement for therapy. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|